Impact of Low-Dose rATG Prior to Matched Sibling Donor Hematopoietic Stem Cell Transplantation for Hematologic Malignancies: Reduced Risk of Chronic Graft-versus-Host Disease and Improved Survival Outcomes.
Zheng-Yang SongHan-Yun RenYu-Jun DongYuan LiYue YinYu Hua SunQian WangWei-Lin XuWei LiuJin-Ping OuZe-Yin LiangPublished in: Cancer management and research (2020)
Low-dose rATG used in MSD-HSCT as part of the conditioning regimen results in a reduced incidence of cGVHD and improves survival outcomes.